Shipped first batches of its COVID 19 vaccine
The Moderna biotech company has shipped the first batches of its COVID-19 vaccine to the US National Institute of Allergy and Infectious Diseases. The trials will be held at Kaiser Permanente Washington Health Research Institute in Seattle. Testing will involve 45 young, healthy volunteers and it uses Moderna's mRNA-1273 vaccine.Unlike a normal vaccine, RNA vaccines work by introducing an mRNA sequence (the molecule which tells cells what to build) which is coded for a disease-specific antigen, once produced within the body, the antigen is recognized by the immune system, preparing it to fight the real thing.
anonymous Coronavirus March 16, 2020 at 8:52 am 1 0
Post a Comment
Search Thoughts
Biotech Categories
Recent Tags
biotech experts cdots nanoparticle pfizer vaccine pfizer biontech vaccine moderna leronlimab cytodyn covid-19 sinovac covid19 vaccine covid-19 coronavirus covid19 clinicaltrial coronavirus vaccine who coronavirus vaccine vaccine novavax covid19 dna vaccine rna biontech
Other sites:Executive Dating
Stupid Coworkers
Business Blog
Good News Network
Coupon Codes
Thought Tags
Get Social and Share